Severe Adverse Reactions
3 clinical trials · Condition
◉ Watch Severe Adverse Reactions
| Record | Firm | Date |
|---|---|---|
| Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study. (NCT04479553) | Zhong Wang | 2020-08-17 |
| Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study (NCT03640884) | Zhong Wang | 2019-02-18 |
| Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study (NCT02239237) | Zhong Wang | 2014-09-01 |
Track Severe Adverse Reactions automatically
Every clearance here is in the API, with alerts when new ones post.